Provided by Tiger Trade Technology Pte. Ltd.

GH Research PLC

14.57
-0.1500-1.02%
Post-market: 14.570.00000.00%16:16 EDT
Volume:102.59K
Turnover:1.49M
Market Cap:903.77M
PE:-18.44
High:14.79
Open:14.20
Low:14.20
Close:14.72
52wk High:19.51
52wk Low:7.98
Shares:62.03M
Float Shares:20.47M
Volume Ratio:0.70
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7900
EPS(LYR):-0.7900
ROE:-21.04%
ROA:-15.92%
PB:3.23
PE(LYR):-18.44

Loading ...

GH Research Up Over 18%, On Track for Largest Percent Increase Since February 2025 -- Data Talk

Dow Jones
·
Jan 08

GH Research Plc : Needham Raises Target Price to $29 From $19

THOMSON REUTERS
·
Jan 06

BUZZ-U.S. STOCKS ON THE MOVE-Synchrony Financial, Coinbase, Versant Media Group

Reuters
·
Jan 06

Sector Update: Health Care Stocks Lower Premarket Monday

MT Newswires Live
·
Jan 05

BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Liberty Energy, Fortive

Reuters
·
Jan 05

A small company can now advance its psychedelic into Phase 3. Here's why that matters to other psychedelic biotechs.

Dow Jones
·
Jan 05

GH Research Plc : RBC Raises Target Price to $33 From $29

THOMSON REUTERS
·
Jan 05

GH Research Shares Jump 44% Premarket After US FDA Lifts Clinical Hold on Depression Drug Trials

THOMSON REUTERS
·
Jan 05

NextEra Energy, GH Research And 3 Stocks To Watch Heading Into Monday

Benzinga
·
Jan 05

GH Research plc Unveils Data on Ultra-Rapid Antidepressant GH001 in Treatment-Resistant Depression

Reuters
·
Jan 05

FDA Lifts Clinical Hold on GH Research's GH001, Allowing U.S. Trials

Reuters
·
Jan 05

GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026

THOMSON REUTERS
·
Jan 05

GH Research Plc - Phase 3 Initiation Targeted for 2026

THOMSON REUTERS
·
Jan 05

GH Research Plc: Company to Seek FDA Alignment on Global Phase 3 Program Replicating Phase 2B Design

THOMSON REUTERS
·
Jan 05

NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM

Reuters
·
Jan 05

Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket

Benzinga_recent_news
·
Jan 05

We Think GH Research (NASDAQ:GHRS) Can Easily Afford To Drive Business Growth

Simply Wall St.
·
Dec 11, 2025

GH Research Reports GH001 Significantly Reduces Depression and Anxiety in Treatment-Resistant Patients

Reuters
·
Nov 24, 2025

RBC Capital Keeps Their Buy Rating on GH Research (GHRS)

TIPRANKS
·
Nov 08, 2025

Cantor Fitzgerald Keeps Their Buy Rating on GH Research (GHRS)

TIPRANKS
·
Nov 07, 2025